EUVIMEDEUVIMED entdecken
Crossref

Tanshinone I attenuates gastric precancerous lesions by inhibiting epithelial mesenchymal transition through the p38/STAT3 pathway

Dan Liang, Shiyun Tang, Lu Liu, Maoyuan Zhao, Xiao Ma, Yanling Zhao, Caifei Shen, Qingsong Liu, Jianyuan Tang, Jinhao Zeng, Nianzhi Chen

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110902 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Dan Liang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. Hauptthemen laut MEDLINE: Abietanes, Stomach Neoplasms, Precancerous Conditions, Gastric Mucosa. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Department of Sichuan Province, Chengdu University of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Gastric precancerous lesions (GPLs) are omens for gastric cancer (GC), which developing with a series of pathological changes of gastric mucosa. Reversing epithelial-mesenchymal transition (EMT) in gastric mucosa is the main approach to restrain GPLs from evolving into cancer. Tanshinone I (Tan-I), the active ingredients of traditional Chinese herb Salvia miltiorrhiza, has exhibited anticancer effect. PURPOSE: To investigate the effect and mechanism of Tan-I in intervening GPLs, and provide a new therapeutic strategy for prevention of GC. METHODS: Gastric mucosal epithelial cells were treated with the N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to construct MNNG-induced cell (MC cell) of gastric mucosa that undergoing EMT process. Then, this study explored the effect and mechanism of Tan-I in vitro. Subsequently, this study constructed GPL mice to clarify the exact efficacy and mechanism of Tan-I on GPLs. RESULTS: Tan-I inhibited MC cell proliferation, invasion and migration. Simultaneously, the aberrant expression of E-cadherin and N-cadherin were reversed. Tan-I attenuated inflammation by reducing the release of nitric oxide, TNFα and IL-1β. Tan-I reversed the EMT and inflammatory processes by regulating p38 and STAT3. CONCLUSION: This study showed that Tan-I inhibited the progression of GPLs by reversing the EMT process and reducing inflammation by restraining the p38/STAT3 signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AbietanesStomach NeoplasmsPrecancerous ConditionsGastric MucosaAnimalsEpithelial-Mesenchymal TransitionSTAT3 Transcription FactorMicep38 Mitogen-Activated Protein KinasesHumansSignal TransductionCell ProliferationMethylnitronitrosoguanidineMaleCell Movement

Stichwörter der Autor:innen

Epithelial-mesenchymal transitionGastric cancerGastric precancerous lesionsTanshinone Ip38/STAT3

Substanzen

AbietanestanshinoneSTAT3 Transcription Factorp38 Mitogen-Activated Protein KinasesMethylnitronitrosoguanidine

Autor:innen und Institutionen

  • Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Department of Pharmacy, Chinese PLA General Hospital, Beijing, China.
  • Department of Endoscopy Center, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Department of Gastroenterology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. Electronic address: tangjy@cdutcm.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Department of Sichuan Province
  • Chengdu University of Traditional Chinese Medicine

Zitieren

APA

Liang, D., Tang, S., Liu, L., Zhao, M., Ma, X., Zhao, Y., Shen, C., Liu, Q., Tang, J., Zeng, J., & Chen, N. (2023). Tanshinone I attenuates gastric precancerous lesions by inhibiting epithelial mesenchymal transition through the p38/STAT3 pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110902

Vancouver

Liang D, Tang S, Liu L, Zhao M, Ma X, Zhao Y, et al. Tanshinone I attenuates gastric precancerous lesions by inhibiting epithelial mesenchymal transition through the p38/STAT3 pathway. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110902

BibTeX
@article{Liang2023,
  author = {Liang, Dan and Tang, Shiyun and Liu, Lu and Zhao, Maoyuan and Ma, Xiao and Zhao, Yanling and Shen, Caifei and Liu, Qingsong and Tang, Jianyuan and Zeng, Jinhao and Chen, Nianzhi},
  title = {Tanshinone I attenuates gastric precancerous lesions by inhibiting epithelial mesenchymal transition through the p38/STAT3 pathway},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110902}
}
Kostenlos starten →